<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-11-21T05:27:32Z</responseDate><request verb="GetRecord" identifier="oai:macsphere.mcmaster.ca:11375/12087" metadataPrefix="dim">https://prod-ms-be.lib.mcmaster.ca/server/oai/request</request><GetRecord><record><header><identifier>oai:macsphere.mcmaster.ca:11375/12087</identifier><datestamp>2026-09-24T20:20:43Z</datestamp><setSpec>com_11375_271</setSpec><setSpec>col_11375_272</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="advisor" lang="en_US">Gerstein, Hertzel C.</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="author" lang="en_US">Yakubovich, Natalia</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="department" lang="en_US">Health Research Methodology</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2014-06-18T16:58:12Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="available">2014-06-18T16:58:12Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="created" lang="en_US">2012-01-20</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued" lang="en_US">2012-04</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other" lang="en_US">opendissertations/7001</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other" lang="en_US">7806</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other" lang="en_US">2461161</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">http://hdl.handle.net/11375/12087</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://doi.org/10.71548/20534</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract" lang="en_US">&lt;p>Current evidence suggests that both prediabetes and diabetes can reverse to normoglycemia; however, predictors of remission of these conditions are poorly understood. We performed analyses on 1,209 people with impaired fasting glucose and/or impaired glucose tolerance treated with placebo rosiglitazone and placebo ramipril in the DREAM trial. Normoglycemia was defined as a fasting plasma glucose &lt;5.6 mmol/L and 2-hour plasma glucose &lt;7.8 mmol/L on a 75 g oral glucose tolerance test (OGTT).&lt;/p> &lt;p>The effects of baseline ALT and waist to hip ratio (WHR) on regression of prediabetes to normoglycemia 2 years later were found to be interdependent (p-value for interaction 0.01). Adjusted odds ratios ORs (95% CI) of regression to normoglycemia per 10 U/L increase in ALT were 0.79 (0.66-0.94) when WHR was at the mean minus 1 standard deviation (SD), 0.90 (0.80-1.02) when WHR was at the mean of 0.91, and 1.03 (0.90-1.18) when WHR was at the mean plus 1 SD. Adjusted ORs of regression to normoglycemia per 0.1 unit increase in WHR were 0.75 (0.60-0.95) when ALT was at the mean minus 1 SD, 0.91 (0.76-1.08) when ALT was at the mean of 25 U/L, and 1.09 (0.89-1.35) when ALT was at the mean plus 1 SD.&lt;/p> &lt;p>Similarly, the effects of baseline ALT and WHR on AUC&lt;sub>glucose0-120 min&lt;/sub> obtained from the OGTT were found to be interdependent (p-value for interaction 0.056). A 10 U/L increase in ALT was associated with an adjusted AUC&lt;sub>glucose0-120 min&lt;/sub> increase of 19.5 (95% CI 5.3 to 33.7) min*mmol/L when WHR was at the mean minus 1 SD, 11.0 (1.4 to 20.6) min*mmol/L when WHR was at the mean of 0.91, and 2.5 (-9.2 to 14.1) min*mmol/L when WHR was at the mean plus 1 SD. A 0.1 unit increase in WHR was associated with an adjusted AUC&lt;sub>glucose0-120 min&lt;/sub> increase of 30.3 (10.2 to 50.3) min*mmol/L when ALT was at the mean minus 1 SD, 18.3 (3.8-32.9) min*mmol/L when ALT was at the mean of 25 U/L, and 6.4 (-11.5 to 24.3) min*mmol/L when ALT was at the mean plus 1 SD.&lt;/p> &lt;p>In conclusion, high baseline ALT and WHR predict a lower likelihood of regression of prediabetes to normoglycemia and an increase in AUC&lt;sub>glucose0-120 min&lt;/sub> 2 years later; however, the effects of ALT and WHR on these outcomes are interdependent.&lt;/p></dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degree" lang="en_US">Master of Science (MSc)</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">fatty liver</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">ALT</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">diabetes</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">normoglycemia</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">anthropometrics</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">glucose</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Nutritional and Metabolic Diseases</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Nutritional and Metabolic Diseases</dim:field>
   <dim:field mdschema="dc" element="title" lang="en_US">Alanine Transaminase and Waist to Hip Ratio as Predictors of Dysglycemia and Regression to Normoglycemia in Adult Patients with Prediabetes</dim:field>
   <dim:field mdschema="dc" element="type" lang="en_US">thesis</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
</dim:dim></metadata></record></GetRecord></OAI-PMH>